{"id":4236,"company":{"country":"CA","currency":"CAD","exchange":"TORONTO STOCK EXCHANGE","ipo":"2011-11-24","marketCap":219.948,"name":"OrganiGram Holdings Inc","phone":"15063841571","outstanding":81.1616,"symbol":"OGI","website":"https://www.organigram.ca/","industry":"Pharmaceuticals"},"price":1.9375,"year":2024,"month":8,"day":16,"weekday":"Friday","title":"Impact of Economic Factors on OrganiGram Holdings Inc Stock Prices","date":"2024-08-16","url":"/posts/2024/08/16/OGI","content":[{"section":"1. Relationship between interest rates and stock prices","text":"Interest rates have a direct impact on the cost of borrowing for companies like OrganiGram Holdings Inc. When interest rates are low, companies can access cheap capital, which can lead to increased investments and expansion. This can positively affect stock prices as investors anticipate higher future earnings. Conversely, when interest rates rise, borrowing becomes more expensive, leading to reduced investment and potential decline in stock prices."},{"section":"2. Effect on consumer spending","text":"Interest rates also influence consumer spending patterns. When interest rates are low, borrowing costs decrease, making it more attractive for consumers to borrow and spend money on products and services. This increased consumer spending can have a positive impact on companies' revenues and profitability, potentially leading to higher stock prices for companies like OrganiGram Holdings Inc. On the other hand, high interest rates can discourage consumers from borrowing and spending, potentially leading to lower revenues and stock prices."},{"section":"3. Inflation and interest rates","text":"The relationship between inflation and interest rates is another important factor to consider. When inflation is high, central banks often increase interest rates to control inflationary pressures. Higher interest rates can make borrowing more expensive for companies, which can lead to decreased investments and potentially lower stock prices. Conversely, when inflation is low, central banks may lower interest rates, which can stimulate investment and potentially result in higher stock prices."},{"section":"4. Market sentiment and interest rates","text":"Interest rates also have an impact on overall market sentiment and investor behavior. When interest rates are low, investors may be more willing to take on risk and invest in stocks, as they seek higher returns compared to low-yielding fixed-income investments. This increased demand for stocks can contribute to higher stock prices for companies like OrganiGram Holdings Inc. Conversely, when interest rates are high, investors may be more inclined to invest in bonds and other fixed-income assets, potentially leading to lower demand for stocks and lower stock prices."},{"section":"5. External economic factors","text":"It is important to note that other external economic factors, such as the overall state of the economy, industry-specific trends, and geopolitical events, can also influence OrganiGram Holdings Inc stock prices. These factors, in combination with interest rates, determine the overall investment climate and market conditions, which can impact investor confidence and the perceived value of stocks."}],"tags":["CrossOver21","Long","Pharmaceuticals"],"news":[{"category":"company","date":1723718880,"headline":"Biotech Alert: Searches spiking for these stocks today","id":129378696,"image":"","symbol":"OGI","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3601819047"},{"category":"company","date":1723621500,"headline":"Organigram: Q3 2024 Earnings Show Improvement In Revenues And Net Income (Hold)","id":129366710,"image":"","symbol":"OGI","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3600168136"},{"category":"company","date":1723615560,"headline":"Cannabis Company, Organigram, Reports An Impressive Q3 Turnaround","id":129366711,"image":"","symbol":"OGI","publisher":"TalkMarkets","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3600910210"},{"category":"company","date":1723604760,"headline":"Canaccord Genuity Remains a Buy on OrganiGram Holdings (OGI)","id":129366712,"image":"","symbol":"OGI","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3600663310"},{"category":"company","date":1723597380,"headline":"OrganiGram Holdings Inc (OGI) Q3 2024 Earnings Call Transcript Highlights: Strong Revenue ...","id":129366713,"image":"","symbol":"OGI","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3599889006"},{"category":"company","date":1723579219,"headline":"Organigram (OGI) Q3 2024 Earnings Call Transcript","id":129344470,"image":"https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg","symbol":"OGI","publisher":"Yahoo","summary":"OGI earnings call for the period ending June 30, 2024.","url":"https://www.fool.com/earnings/call-transcripts/2024/08/13/organigram-ogi-q3-2024-earnings-call-transcript/?source=eptyholnk0000202\u0026amp;utm_source=yahoo-host-full\u0026amp;utm_medium=feed\u0026amp;utm_campaign=article\u0026amp;referring_guid=a53c3c50-50ae-43a8-aba0-cf68b34b5422\u0026amp;.tsrc=rss"},{"category":"company","date":1723548900,"headline":"Why Is Organigram (OGI) Stock Up 25% Today?","id":129341408,"image":"","symbol":"OGI","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3598933556"},{"category":"company","date":1723547984,"headline":"OrganiGram: Fiscal Q3 Earnings Snapshot","id":129328483,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"OGI","publisher":"Yahoo","summary":"TORONTO (AP) — OrganiGram Holdings Inc. OGI) on Tuesday reported fiscal third-quarter earnings of $2.1 million. On a per-share basis, the Toronto-based company said it had net income of 2 cents.","url":"https://finance.yahoo.com/news/organigram-fiscal-q3-earnings-snapshot-111944236.html"},{"category":"company","date":1723546841,"headline":"Organigram Up 4.9% in U.S. Premarket After Q3 Profit Figures Released","id":129328484,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"OGI","publisher":"Yahoo","summary":"Organigram Up 4.9% in U.S. Premarket After Q3 Profit Figures Released","url":"https://finance.yahoo.com/news/organigram-4-9-u-premarket-110041804.html"},{"category":"company","date":1723546680,"headline":"OGI Stock Earnings: OrganiGram Holdings Beats EPS, Beats Revenue for Q3 2024","id":129341409,"image":"","symbol":"OGI","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3598888888"},{"category":"company","date":1723545000,"headline":"Organigram Reports Third Quarter Fiscal 2024 Results","id":129328485,"image":"https://media.zenfs.com/en/business-wire.com/569a0a4071f820f8706b1ba68e7c0f8b","symbol":"OGI","publisher":"Yahoo","summary":"TORONTO, August 13, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the \"Company\" or \"Organigram\"), a leading licensed producer of cannabis, announced its results for the third quarter ended June 30, 2024 (\"Q3 Fiscal 2024\").","url":"https://finance.yahoo.com/news/organigram-reports-third-quarter-fiscal-103000048.html"},{"category":"company","date":1723541527,"headline":"Organigram Holdings Inc. (OGI) Q3 2024 Earnings Call Transcript","id":129329010,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"OGI","publisher":"SeekingAlpha","summary":"Organigram Holdings Inc. (NASDAQ:NASDAQ:OGI) Q3 2024 Earnings Conference Call August 13, 2024 8:00 AM ETCompany ParticipantsMax Schwartz - Director of...","url":"https://seekingalpha.com/article/4714008-organigram-holdings-inc-ogi-q3-2024-earnings-call-transcript"},{"category":"company","date":1723535820,"headline":"Organigram Reports 25% YoY Increase In Q3 Net Revenue, Significant Improvement In Adjusted EBITDA","id":129341413,"image":"","symbol":"OGI","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3598688951"},{"category":"company","date":1723529340,"headline":"Options Volatility and Implied Earnings Moves Today, August 13, 2024","id":129332796,"image":"","symbol":"OGI","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3598594493"},{"category":"company","date":1723529340,"headline":"Organigram Holdings Sees Robust Growth in Q3","id":129341417,"image":"","symbol":"OGI","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3598594489"},{"category":"company","date":1723527480,"headline":"Organigram Holdings reports Q3 results","id":129341421,"image":"","symbol":"OGI","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3598574938"},{"category":"company","date":1723527300,"headline":"Organigram reports Q3 revenue C$41.1M vs. C$32.8M last year","id":129341423,"image":"","symbol":"OGI","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3598572959"},{"category":"company","date":1723519920,"headline":"Cannabis Stock Movers For August 13, 2024","id":129337426,"image":"","symbol":"OGI","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3599226160"},{"category":"company","date":1723459380,"headline":"Organigram Holdings Q3 2024 Earnings Preview","id":129318235,"image":"","symbol":"OGI","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3597286674"},{"category":"company","date":1723442460,"headline":"Options Volatility and Implied Earnings Moves This Week, August 12 – August 15, 2024","id":129312014,"image":"","symbol":"OGI","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3596994990"},{"category":"company","date":1723439040,"headline":"Here is the next potential market catalyst","id":129319374,"image":"","symbol":"OGI","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3597800553"},{"category":"company","date":1723115580,"headline":"Organigram's Promising Results From Nanoemulsion Technology Study To Improve Cannabis Edibles","id":129251543,"image":"","symbol":"OGI","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3592197837"},{"category":"company","date":1723087800,"headline":"Cannabis Stock Movers For August 8, 2024","id":129241270,"image":"","symbol":"OGI","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3592665552"},{"category":"company","date":1723026141,"headline":"Organigram Says Product Development Collaboration Completes Clinical Study on Nanoemulsion Technology","id":129199775,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"OGI","publisher":"Yahoo","summary":"Organigram Says Product Development Collaboration Completes Clinical Study on Nanoemulsion Technology","url":"https://finance.yahoo.com/news/organigram-says-product-development-collaboration-102221944.html"},{"category":"company","date":1723024800,"headline":"Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology","id":129198528,"image":"https://media.zenfs.com/en/business-wire.com/92242e119e9409b8d487fac6c2235bf5","symbol":"OGI","publisher":"Yahoo","summary":"TORONTO, August 07, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of cannabis, is pleased to unveil the preliminary results of its landmark clinical pharmacokinetic (PK) study conducted via the Product Development Collaboration (PDC) on its latest innovation, nanoemulsion technology. This patent-pending technology, branded FAST™ (Fast Acting Soluble Technology), will be the first innovation to be commercialized by Organigram leveraging the output of the PDC","url":"https://finance.yahoo.com/news/organigram-product-development-collaboration-completes-100000994.html"},{"category":"company","date":1723009140,"headline":"Organigram’s Nanoemulsion Tech Revolutionizes Cannabis Consumption","id":129204751,"image":"","symbol":"OGI","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3589777647"},{"category":"company","date":1722947220,"headline":"IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now","id":129178496,"image":"","symbol":"OGI","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588498823"},{"category":"company","date":1722938400,"headline":"Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024","id":129173363,"image":"https://media.zenfs.com/en/business-wire.com/3a0f73c4148dc8e0ee086289e674f171","symbol":"OGI","publisher":"Yahoo","summary":"TORONTO, August 06, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the \"Company\" or \"Organigram\"), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter fiscal 2024 ended June 30, 2024, on Tuesday, August 13, 2024, prior to market open.","url":"https://finance.yahoo.com/news/organigram-report-third-quarter-fiscal-100000993.html"},{"category":"company","date":1722922740,"headline":"Organigram to Unveil Q3 Fiscal 2024 Financial Results","id":129178498,"image":"","symbol":"OGI","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3587991475"},{"category":"company","date":1722915000,"headline":"Marijuana Stock Movers For August 6, 2024","id":129185657,"image":"","symbol":"OGI","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588754657"},{"category":"company","date":1722888389,"headline":"The 3 Best Cannabis Stocks to Buy in August 2024","id":129315904,"image":"https://media.zenfs.com/en/investorplace_417/7619ee6f78f4a18f3501a8e93a161845","symbol":"OGI","publisher":"Yahoo","summary":"Cannabis stocks initially sounded like a compelling opportunity when Canada became the first G7 nation to legalize recreational marijuana. At the time, the popular belief was that the U.S. would eventually follow suit. After all, the war on drugs has largely been a failure. Concerns also sprouted to the forefront about the social injustices tied to drug law enforcement. Unfortunately, cannabis stocks skyrocketed then cratered. What happened? The bottom line was that the sector suffered from a cl","url":"https://finance.yahoo.com/news/3-best-cannabis-stocks-buy-200629719.html"},{"category":"company","date":1722569640,"headline":"Marijuana Stock Movers For August 2, 2024","id":129111474,"image":"","symbol":"OGI","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583840834"}]}